|
ZNF860 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30950805754537E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.92550428326876E-11 |
| Normal-vs-Stage2 |
5.803700E-03 |
| Normal-vs-Stage3 |
8.28440000044672E-07 |
| Normal-vs-Stage4 |
7.54720000000209E-05 |
| Stage1-vs-Stage2 |
4.966200E-01 |
| Stage1-vs-Stage3 |
3.193400E-01 |
| Stage1-vs-Stage4 |
8.127400E-01 |
| Stage2-vs-Stage3 |
9.581400E-01 |
| Stage2-vs-Stage4 |
7.036600E-01 |
| Stage3-vs-Stage4 |
6.434000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11926048826672E-12 |
| Normal-vs-AfricanAmerican |
2.799300E-03 |
| Normal-vs-Asian |
9.52779999999764E-05 |
| Caucasian-vs-AfricanAmerican |
1.967960E-01 |
| Caucasian-vs-Asian |
4.462800E-01 |
| AfricanAmerican-vs-Asian |
3.611600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70329999993335E-07 |
| Normal-vs-Female |
7.53597184655064E-12 |
| Male-vs-Female |
6.034600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.27190521740317E-11 |
| Normal-vs-Age(41-60Yrs) |
5.35669999468524E-08 |
| Normal-vs-Age(61-80Yrs) |
9.5293999999968E-05 |
| Normal-vs-Age(81-100Yrs) |
2.283900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.092630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.158200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.379800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.722000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.475400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.793600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.123800E-01 |
| Classical-VS-Follicular |
4.258200E-03 |
| Classical-VS-Other |
8.823400E-01 |
| Classical-VS-Normal |
2.1316282072803E-14 |
| Tall-VS-Follicular |
2.581400E-01 |
| Tall-VS-Other |
8.187400E-01 |
| Tall-VS-Normal |
3.409600E-04 |
| Follicular-VS-Other |
4.339400E-01 |
| Follicular-VS-Normal |
5.902000E-03 |
| Other-VS-Normal |
2.166000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.22339999639476E-08 |
| Normal-vs-N1 |
6.838900E-04 |
| N0-vs-N1 |
9.492000E-01 |
|
|
